Akero Therapeutics (AKRO) P/E (2019 - 2025)
Akero Therapeutics (AKRO) P/E from Jul 1, 2019 to Dec 9, 2025. The TTM Akero Therapeutics (AKRO) P/E is -8.72. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Akero Therapeutics (AKRO)
| Year | P/E | Change |
|---|---|---|
| 2025 | -8.72 | +91.34% |
| 2024 | -4.56 | -54.86% |
| 2023 | -10.09 | -41.75% |
| 2022 | -17.32 | +136.80% |
| 2021 | -7.32 | +9.92% |
| 2020 | -6.66 | -59.69% |
| 2019 | -16.51 | N/A |
Comparison Akero Therapeutics (AKRO) P/E with competitors
Akero Therapeutics (AKRO) P/E is -8.72.